Home Top Movers What’s Driving Ocugen (OCGN) Stock Higher Pre-Market Today?

What’s Driving Ocugen (OCGN) Stock Higher Pre-Market Today?

The drugmaker Ocugen Inc (OCGN) has been surging nearly 4% at the start of the premarket session today. Before that, the previous session on Friday also came to be impressive for the stock as it closed with a rise of 36.87% to $10.95. Today’s premarket surged could be attributed to news surfaced from the Asian region that the Indian prime minister took his first vaccine shot today morning, which was of COVAXIN, a vaccine candidate the Ocugen has also been developing for U.S. markets in collaboration with an Indian firm.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.  

What really is happening?


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Biopharmaceutical company Ocugen, Inc. focuses its efforts on the discovery, development, and commercialization of gene therapies for the treatment of blindness diseases and has also been developing a vaccine to protect people from COVID-19. Its breakthrough gene therapy platform can treat a variety of retinal diseases by providing one therapy for multiple diseases. Innovative therapies for patients with chronic diseases such as wet macular degeneration, diabetic macular edema, and diabetic retinopathy will be available through its novel biologic candidate. Covaxin vaccine candidate for COVID-19 is being developed in the U.S. market by the company in conjunction with Bharat Biotech.

Read More

It was announced last week that Ocugen’s OCU400 has been recommended by the European Medicines Agency (EMA) for the treatment of Leber congenital amaurosis and retinitis pigmentosa (RP).

  • The European Commission has granted orphan medicinal product designation to the drug based on that recommendation.
  • There are approximately 165,000 patients with RP in Europe and 40,000 patients with LCA in the region.
  • According to estimates, approximately 2.0 million people reside in the world with RP, and 0.2 million suffer from LCA.
  • An orphan medicinal drug designation in Europe offers certain benefits to a company while it develops drugs for treating, diagnosing, or preventing diseases and conditions that affect fewer than 5 out of 10,000 patients in the region.
  • The government will assist companies in obtaining protocol assistance, reduced regulatory charges, research grants, and ten years of market exclusivity following regulatory approval of such designated products.

    Get the hottest stocks to trade every day before the market opens 100% free. Click here now.  

Conclusion:

The Ocugen stock could continue the rally today that it has started in last trading, or can at least raise the investor’s sentiment for a while in pre-market as well as regular session today. However, its potential could be counted higher as its co-developed vaccine for vast market of India could bring in strong revenues at an accelerated pace.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Onesmart International Education Group Ltd. (ONE) stock surges during current market. What’s driving it high?

Onesmart International Education Group Ltd. (NASDAQ: ONE) stock gains by 111.86% in the current market trading session. OneSmart International Education is a major Chinese...

LivePerson Inc. (LPSN) stock plunge during pre-market. What’s driving it low?

LivePerson Inc. (NASDAQ: LPSN) stock gained by 0.86% at last close whereas the LPSN stock declines by 9.39% in the pre-market trading session. Through...

The Clorox Company Ltd. (CLX) stock decline during pre-market. Here’s the recent update

The Clorox Company Ltd. (NASDAQ: CLX) stock gained by 0.17% at last close whereas the CLX stock price fell by 11.59% in the pre-market....

IT Tech Packaging Inc. (ITP) stock gains during pre-market. Here’s what’s happening?

IT Tech Packaging Inc. (NASDAQ: ITP) stock gained by 7.53% at last close while the ITP stock price rises by 2.04% in the pre-market...

Why did The9 Limited (NCTY) stock turnaround in the after-hours on Friday?

The9 Limited (NCTY) shares gained 6.87% in after-hours on Friday, July 30, 2021, and closed the weekly trading at $11.98 per share. in the...

OneConnect Financial Technology Inc. (OCFT) stock plunge during current market. Here’s what you should know.

OneConnect Financial Technology Inc. (NASDAQ: OCFT) stock declines by 22.12% in the current market trading. In China, OneConnect is the most popular technology-as-a-service platform...

Invitae Corporation Inc. (NVTA) stock surge during current market. Here’s the update:

Invitae Corporation Inc. (NASDAQ: NVTA) stock gains by 12.35% in the current market trading session. Invitae Corporation is a prominent medical genetics business whose...

LivePerson Inc. (LPSN) stock plunge during pre-market. What’s driving it low?

LivePerson Inc. (NASDAQ: LPSN) stock gained by 0.86% at last close whereas the LPSN stock declines by 9.39% in the pre-market trading session. Through...

Related News

Here is why Activision Blizzard Inc. (ATVI) stock turnaround in the after-hours on Tuesday?

Activision Blizzard Inc. (ATVI) shares gained 6.10% in after-hours on Tuesday, August 03, 2021, and closed the daily trading at $84.70 per share. Earlier...

Lixte Biotechnology Holdings Inc. (LIXT) stock surge during current market. Here’s the recent news

Lixte Biotechnology Holdings Inc. (NASDAQ: LIXT) stock gains by 32.32% in the current market trading session. Lixte Biotechnology Holdings is a clinical-stage pharmaceutical business...

Arcturus Therapeutics Inc. (ARCT) stock surged during pre-market. Here’s the latest news.

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) stock gained by 10.7% at last close while the ARCT stock rises by 7.53% in the pre-market trading...

Here is why Ramaco Resources Inc. (METC) stock performed well on Monday?

Ramaco Resources Inc. (METC) shares surged 9.46% in after-hours on Monday, August 2, 2021, and closed the daily trading at $7.29 per share. in...

General Electric Company Inc. (GE) stock sky-rocketing during pre-market. Here’s what you should know

General Electric Company Inc. (NASDAQ: GE) stock plunged by 2.56% at last close whereas the GE stock price surged massively during pre-market by 704.32%....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam